Searched for
CANCER TREATMENT PACKAGES
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...- Time to take the first step to become a contrarian? 4 mid-cap stocks from different sectors with upside potential up to 21%As the risk created by the US-Iran war keeps crude oil prices elevated, the list of stocks where investors can deploy fresh money with comf...
- Mamata Banerjee’s Swasthya Sathi Scheme faces uncertainty as Kolkata Hospitals restrict admissionsPatients on West Bengal's Swasthya Sathi health scheme face admission hurdles at Kolkata's private hospitals. Uncertainty surrounds the sch...
- Why this US doctor eats as if he has cancer, even though he doesn’t. Check his diet & the reason behind itA viral post by Dr Josh Axe on Instagram is pushing a proactive approach to health, where an “anti-cancer diet” is followed not as a cure, ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
- Colorectal cancer early signs: What doctors say young adults should stop ignoringA survey reveals alarming low awareness of colorectal cancer symptoms in Delhi, with over 80% of young and working-age adults failing to id...
- Cancer care under Ayushman Bharat needs Rs 33,000 crore annually, far above current allocation: StudyIndia's Ayushman Bharat health scheme is a lifeline for cancer patients, improving access to treatment. A new study highlights its strength...
- Parliamentary panel bats for affordable cancer insuranceA parliamentary panel has suggested standardised cancer diagnostic packages under government insurance to broaden inclusion. It has advocat...
- Cancer care startup Onco pulls down shutters as unit economics biteOnco acted as an aggregator platform for hospitals and provided online consultancy services for cancer patients. It also allowed patients t...
- People living by river drains more prone to cancer: ICMR cites studyA 2024 study found that individuals living near river drains are at a high risk of cancer. The Indian government has approved various initi...
- DCGI orders withdrawal of cancer drug Olaparib for certain treatmentsThe Drug Controller General of India has requested the withdrawal of AstraZeneca's Olaparib tablets for certain cancer treatments due to po...
- 6 crore hospital admissions costing Rs 77,298 cr authorised under AB PM-JAY till Nov 30: Govt to LSThe Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) has authorized approximately six crore hospital admissions worth Rs 77,298...
- Postage stamp to celebrate Ayushman Bharat's Ist anniversaryA revamp of medical packages, improved patient care, brainstorming two-day convention with state health ministers to chart out the course a...
Load More
